1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical Trials Review, H1, 2016

Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, “Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical Trials Review, H1, 2016" provides an overview of Choriocarcinoma (Gestational Trophoblastic Neoplasia) clinical trials scenario. This report provides top line data relating to the clinical trials on Choriocarcinoma (Gestational Trophoblastic Neoplasia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical Trials Review, H1, 2016
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Choriocarcinoma (Gestational Trophoblastic Neoplasia) to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Choriocarcinoma (Gestational Trophoblastic Neoplasia) to Oncology Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials 25
Prominent Drugs 26
Latest Clinical Trials News on Choriocarcinoma (Gestational Trophoblastic Neoplasia) 27
Mar 21, 2016: TRACON Pharmaceuticals Reports Updated Positive Data on Ongoing Complete Response in Choriocarcinoma Patient Treated with TRC105 27
Clinical Trial Profile Snapshots 28
Appendix 50
Abbreviations 50
Definitions 50
Research Methodology 51
Secondary Research 51
About GlobalData 52
Contact Us 52
Disclaimer 52
Source 53

List of Tables
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics, Global, Clinical Trials by Region, 2016* 6
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Proportion of Choriocarcinoma (Gestational Trophoblastic Neoplasia) to Oncology Clinical Trials, G7 Countries (%), 2016* 13
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Choriocarcinoma (Gestational Trophoblastic Neoplasia) to Oncology Clinical Trials, E7 Countries (%), 2016* 16
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics, Global, Clinical Trials by Phase, 2016* 18
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 19
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 20
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 21
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 22
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 23
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 24
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 25
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26

List of Figures
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
Proportion of Choriocarcinoma (Gestational Trophoblastic Neoplasia) to Oncology Clinical Trials, G7 Countries (%), 2016* 13
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Choriocarcinoma (Gestational Trophoblastic Neoplasia) to Oncology Clinical Trials, E7 Countries (%), 2016* 16
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 18
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 19
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 20
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 21
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 22
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 23
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 24
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 25
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26
GlobalData Methodology 51

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Chronic Myelocytic Leukemia (CML) - Market Insights, Epidemiology and Market Forecast-2023

Chronic Myelocytic Leukemia (CML) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Chronic Myelocytic Leukemia (CML) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the ...

Acute Myeloid Leukemia (AML) - Market Insights, Epidemiology and Market  Forecast-2023

Acute Myeloid Leukemia (AML) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Acute Myeloid Leukemia (AML) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Chronic lymphocytic leukemia- Market Insights, Epidemiology and Market Forecast-2023

Chronic lymphocytic leukemia- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Chronic lymphocytic leukemia - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the US

  • December 2016
    112 pages
  • Cancer  

  • United States  

    North America  

View report >

Therapy Market in the UK

  • November 2016
    11 pages
  • Therapy  

  • United Kingdom  

View report >

Cancer Statistics in Russia

  • November 2016
    8 pages
  • Leukemia  

    Cancer  

    Radiography  

  • Russian Federat...  

View report >

Related Market Segments :

Leukemia
Lymphoma
Therapy
Chemotherapy
Clinic

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.